ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Pampiglione S, Fioravanti ML, Gustinelli A, Onore G, Mantovani B, Luchetti A, Trentini M, 2009. Sand flea (Tunga spp.) infections in humans and domestic animals: state of the art. Med Vet Entomol 23: 172–186.
-
2.
World Health Organization/Department of Control of Neglected Tropical Diseases , 2018. Recognizing Neglected Tropical Diseases Through Changes on the Skin: A Training Guide for Front-Line Health Workers. Available at: http://www.who.int/neglected_diseases/resources/9789241513531/en/. Accessed October 9, 2018.
-
3.
World Health Organization , 2020. Scabies and Other Ectoparasites. Available at: https://www.who.int/neglected_diseases/diseases/scabies-and-other-ectoparasites/en/index1.html. Accessed February 6, 2020.
-
4.
Heukelbach J, de Oliveira FA, Hesse G, Feldmeier H, 2001. Tungiasis: a neglected health problem of poor communities. Trop Med Int Health 6: 267–272.
-
5.
Miller H, Trujillo-Trujillo J, Mutebi F, Feldmeier H, 2020. Efficacy and safety of dimeticones in the treatment of epidermal parasitic skin diseases with special emphasis on tungiasis: an evidence-based critical review. Braz J Infect Dis 24: 170–177.
-
6.
Muehlen M, Heukelbach J, Wilcke T, Winter B, Mehlhorn H, Feldmeier H, 2003. Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: II. Prevalence, parasite load and topographic distribution of lesions in the population of a traditional fishing village. Parasitol Res 90: 449–455.
-
7.
Wilcke T, Heukelbach J, César Sabóia Moura R, Regina Sansigolo Kerr-Pontes L, Feldmeier H, 2002. High prevalence of tungiasis in a poor neighbourhood in Fortaleza, northeast Brazil. Acta Trop 83: 255–258.
-
8.
Ugbomoiko US, Ofoezie IE, Heukelbach J, 2007. Tungiasis: high prevalence, parasite load, and morbidity in a rural community in Lagos State, Nigeria. Int J Dermatol 46: 475–481.
-
9.
Feldmeier H, Eisele M, Van Marck E, Mehlhorn H, Ribeiro R, Heukelbach J, 2004. Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: IV. Clinical and histopathology. Parasitol Res 94: 275–282.
-
10.
Ministry of Health , 2014. National Policy Guidelines on Prevention and Control of Jigger Infestations. Available at: http://guidelines.health.go.ke/#/category/12/95/meta. Accessed October 3, 2018.
-
11.
Ministry of Health , 2012. Press Statement on New Master Plan to Tackle Targeted Neglected Tropical Diseases. Available at: http://www.health.go.ug/docs/Press%20statement%20on%20NTDs.pdf. Accessed October 2, 2018.
-
12.
Ahadi Kenya Trust , 2011. The Jigger Menace in Kenya Report. Available at: http://www.jigger-ahadi.org/index.html. Accessed October 2, 2018.
-
13.
Jawoko K, 2011. Jiggers outbreak in Uganda. Can Med Assoc J 183: E33–E34.
-
14.
Herbinger KH, Siess C, Nothdurft HD, von Sonnenburg F, Loscher T, 2011. Skin disorders among travellers returning from tropical and non-tropical countries consulting a travel medicine clinic. Trop Med Int Health 16: 1457–1464.
-
15.
Heukelbach J, Gomide M, Araújo JF, Pinto NSR, Santana RD, Brito JRM, Feldmeier H, 2007. Cutaneous larva migrans and tungiasis in international travelers exiting Brazil: an airport survey. J Travel Med 14: 374–380.
-
16.
Grupper M, Potasman I, 2012. Outbreak of tungiasis following a trip to Ethiopia. Travel Med Infect Dis 10: 220–223.
-
17.
Belaz S, Gay E, Robert-Gangneux F, Beaucournu JC, Guiguen C, 2015. Tungiasis outbreak in travelers from Madagascar. J Travel Med 22: 263–266.
-
18.
Ugbomoiko US, Ariza L, Ofoezie IE, Heukelbach J, 2007. Risk factors for tungiasis in Nigeria: identification of targets for effective intervention. PLoS Negl Trop Dis 1: e87.
-
19.
Muehlen M, Feldmeier H, Wilcke T, Winter B, Heukelbach J, 2006. Identifying risk factors for tungiasis and heavy infestation in a resource-poor community in northeast Brazil. Trans R Soc Trop Med Hyg 100: 371–380.
-
20.
Franck S, Feldmeier H, Heukelbach J, 2003. Tungiasis: more than an exotic nuisance. Travel Med Infect Dis 1: 159–166.
-
21.
Eisele M, Heukelbach J, Van Marck E, Mehlhorn H, Meckes O, Franck S, Feldmeier H, 2003. Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: I. Natural history of tungiasis in man. Parasitol Res 90: 87–99.
-
22.
Feldmeier H, Eisele M, Sabóia-Moura RC, Heukelbach J, 2003. Severe tungiasis in underprivileged communities: case series from Brazil. Emerg Infect Dis 9: 949–955.
-
23.
Elson L, Fillinger U, Feldmeier H, Tyring SK, Lupi O & Hengge UR Tropical Dermatology ,2nd edition. London, United Kingdom: Elsevier BV, 401–404.
-
24.
Linardi PM, Calheiros CM, Campelo-Junior EB, Duarte EM, Heukelbach J, Feldmeier H, 2010. Occurrence of the off-host life stages of Tunga penetrans (Siphonaptera) in various environments in Brazil. Ann Trop Med Parasitol 104: 337–345.
-
25.
Feldmeier H, Keysers A, 2013. Tungiasis – a Janus-faced parasitic skin disease. Travel Med Infect Dis 11: 357–365.
-
26.
Feldmeier H, Sentongo E, Krantz I, 2013. Tungiasis (sand flea disease): a parasitic disease with particular challenges for public health. Eur J Clin Microbiol Infect Dis 32: 19–26.
-
27.
Feldmeier H, Heukelbach J, Eisele M, Sousa AQ, Barbosa LMM, Carvalho CBM, 2002. Bacterial superinfection in human tungiasis. Trop Med Int Health 7: 559–564.
-
28.
Nyangacha RM et al., 2017. Secondary bacterial infections and antibiotic resistance among tungiasis patients in western, Kenya. PLoS Negl Trop Dis 11: e0005901.
-
29.
Veraldi S, Valsecchi M, 2007. Imported tungiasis: a report of 19 cases and review of the literature. Int J Dermatol 46: 1061–1066.
-
30.
Miller H, Ocampo J, Ayala A, Trujillo J, Feldmeier H, 2019. Very severe tungiasis in Amerindians in the Amazon lowland of Colombia: a case series. PLOS Negl Trop Dis 13: e0007068.
-
31.
Josephine N, Peter NK, Walter M, 2015. Impact of tungiasis on acquisition of basic education among children aged 5–14 years in Murang’a County, Kenya. Int J Sci Res Innov Technol 2: 128–142.
-
32.
Josephine N, Peter NK, Walter M, 2015. Quantifying burden of disease caused by tungiasis using disability adjusted life years metric among the children aged 5–14 years in Murang'a county, Kenya. Int Res J Public Environ Health 2: 151–158.
-
33.
Wiese S, Elson L, Feldmeier H, 2018. Tungiasis-related life quality impairment in children living in rural Kenya. PLOS Negl Trop Dis 12: e0005939.
-
34.
Kimotho S, Miller AN, Ngure P, 2015. Managing communication surrounding tungiasis stigma in Kenya. Communicatio 41: 523–542.
-
35.
Centers for Disease Control and Prevention , 2018. One Health. Available at: https://www.cdc.gov/onehealth/index.html. Accessed June 19, 2020.
-
36.
Feldmeier H, Heukelbach J, Ugbomoiko US, Sentongo E, Mbabazi P, von Samson-Himmelstjerna G, Krantz I, The International Expert Group for T , 2014. Tungiasis—a neglected disease with many challenges for global public health. PLoS Negl Trop Dis 8: e3133.
-
37.
Heukelbach J, 2005. Tungiasis: invited review. Rev Inst Med Trop São Paulo 47: 307–313.
-
38.
Buckendahl J, Heukelbach J, Ariza L, Kehr JD, Seidenschwang M, Feldmeier H, 2010. Control of tungiasis through intermittent application of a plant-based repellent: an intervention study in a resource-poor community in Brazil. PLoS Negl Trop Dis 4: e879.
-
39.
Thielecke M, Raharimanga V, Rogier C, Stauss-Grabo M, Richard V, Feldmeier H, 2013. Prevention of tungiasis and tungiasis-associated morbidity using the plant-based repellent Zanzarin: a randomized, controlled field study in rural Madagascar. PLoS Negl Trop Dis 7: e2426.
-
40.
Feldmeier H, Kehr JD, Heukelbach J, 2006. A plant-based repellent protects against Tunga penetrans infestation and sand flea disease. Acta Trop 99: 126–136.
-
41.
Schwalfenberg S, Witt LH, Kehr JD, Feldmeier H, Heukelbach J, 2004. Prevention of tungiasis using a biological repellent: a small case series. Ann Trop Med Parasitol 98: 89–94.
-
42.
Heukelbach J, 2006. Revision on tungiasis: treatment options and prevention. Expert Rev Anti Infect Ther 4: 151–157.
-
43.
Elson L, Wright K, Swift J, Feldmeier H, 2017. Control of tungiasis in absence of a roadmap: grassroots and global approaches. Trop Med Infect Dis 2: 33.
-
44.
Winter B, Oliveira FA, Wilcke T, Heukelbach J, Feldmeier H, 2009. Tungiasis-related knowledge and treatment practices in two endemic communities in northeast Brazil. J Infect Dev Ctries 3: 458–466.
-
45.
Karunamoorthi K, 2013. Tungiasis: a neglected epidermal parasitic skin disease of marginalized populations—a call for global science and policy. Parasitol Res 112: 3635–3643.
-
46.
Cardoso A, 1981. Generalized tungiasis treated with thiabendazole. Arch Dermatol 117: 127.
-
47.
Heukelbach J, Wilcke T, Winter B, Sales de Oliveira FA, Saboia Moura RC, Harms G, Liesenfeld O, Feldmeier H, 2004. Efficacy of ivermectin in a patient population concomitantly infected with intestinal helminths and ectoparasites. Arzneimittelforschung 54: 416–421.
-
48.
Mitchell CJ, Stephany P, 2013. Infestation of Tunga penetrans in villages near Zomba Central Hospital. Malawi Med J 25: 88–89.
-
49.
Abrha S, Heukelbach J, Peterson GM, Christenson JK, Carroll S, Kosari S, Bartholomeus A, Feldmeier H, Thomas J, 2021. Clinical interventions for tungiasis (sand flea disease): a systematic review. Lancet Infect Dis 21: E234–E245.
-
50.
Ade-Serrano MA, Olomolehin OG, Adewunmi A, 1982. Treatment of human tungiasis with niridazole (ambilhar) a double-blind placebo-controlled trial. Ann Trop Med Parasitol 76: 89–92.
-
51.
Thielecke M, Nordin P, Ngomi N, Feldmeier H, 2014. Treatment of tungiasis with dimeticone: a proof-of-principle study in rural Kenya. PLOS Negl Trop Dis 8: e3058.
-
52.
Nordin P, Thielecke M, Ngomi N, Mudanga GM, Krantz I, Feldmeier H, 2017. Treatment of tungiasis with a two-component dimeticone: a comparison between moistening the whole foot and directly targeting the embedded sand fleas. Trop Med Health 45: 6.
-
53.
Heukelbach J, Franck S, Feldmeier H, 2004. Therapy of tungiasis: a double-blinded randomized controlled trial with oral ivermectin. Mem Inst Oswaldo Cruz 99: 873–876.
-
54.
Heukelbach J, Eisele M, Jackson A, Feldmeier H, 2003. Topical treatment of tungiasis: a randomized, controlled trial. Ann Trop Med Parasitol 97: 743–749.
-
55.
Elson L, Randu K, Feldmeier H, Fillinger U, 2019. Efficacy of a mixture of neem seed oil (Azadirachta indica) and coconut oil (Cocos nucifera) for topical treatment of tungiasis. A randomized controlled, proof-of-principle study. PLOS Negl Trop Dis 13: e0007822.
-
56.
Kamau T, House SK, 2014. The potential risk of HIV infection and transmission of other blood-borne pathogens through the sharing of needles and pins among people infested with jiggers in Kenya. Int J Health Sci Res 4: 278–285.
-
57.
Williamson EM, 2007. The medicinal use of essential oils and their components for treating lice and mite Infestations. Nat Prod Commun 2: 1303–1310.
-
58.
Deyno S, Mtewa AG, Abebe A, Hymete A, Makonnen E, Bazira J, Alele PE, 2019. Essential oils as topical anti-infective agents: a systematic review and meta-analysis. Complement Med Ther 47: 102224.
-
59.
Carson CF, Hammer KA, Riley TV, 2006. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 19: 50–62.
-
60.
Thomas J et al., 2016. Therapeutic potential of tea tree oil for scabies. Am J Trop Med Hyg 94: 258–266.
-
61.
Riley T, 2002. Topical antimicrobial therapy with tea tree oil: fact or fantasy. J Infect Control 3: 12–15.
-
62.
Larkman T, 2021. Communication of Research Findings to Tea Tree Oil Industry Levy Payers. Available at: https://www.agrifutures.com.au/wp-content/uploads/2021/01/20-135.pdf. Accessed May 21, 2021.
-
63.
Sailer R, Berger T, Reichling J, Harkenthal M, 1998. Pharmaceutical and medicinal aspects of Australian tea tree oil. Phytomedicine 5: 489–495.
-
64.
Yadav E, Kumar S, Mahant S, Khatkar S, Rao R, 2017. Tea tree oil: a promising essential oil. J Essent Oil Res 29: 201–213.
-
65.
Australian Tea Tree Industry Association (ATTIA) , 2021. Australian Tea Tree Oil. Available at: https://teatree.org.au/teatree_about_quality.php. Accessed May 21, 2021.
-
66.
Wong YF, Davies NW, Chin S-T, Larkman T, Marriott PJ, 2015. Enantiomeric distribution of selected terpenes for authenticity assessment of Australian Melaleuca alternifolia oil. Ind Crops Prod 67: 475–483.
-
67.
Medicines and Healthcare products Regulatory Agency , 2019. Guidance on Herbal Medicines Granted a Traditional Herbal Registration. Available at: https://www.gov.uk/government/publications/herbal-medicines-granted-a-traditional-herbal-registration-thr/herbal-medicines-granted-a-traditional-herbal-registration. Accessed February 11, 2020.
-
68.
The Therapeutic Goods Administration , 2020. Australian Regulatory Guidelines for Sunscreens (ARGS). Available at: https://www.tga.gov.au/. Accessed October 2, 2019.
-
69.
Poisons Standard 2019 , 2019. Standard for the Uniform Scheduling of Medicines and Poisons No. 23 (the SUSMP 23). Available at: https://www.legislation.gov.au/Details/F2019L00032. Accessed February 11, 2020.
-
70.
European Medicines Agency , EMA/814441/2016, 2017. Tea Tree Oil Herbal Medicine: Summary for the Public. Available at: https://www.ema.europa.eu/en/medicines/herbal/melaleucae-aetheroleum. Accessed February 17, 2020.
-
71.
Hammer KA, Carson CF, Riley TV, Nielsen JB, 2006. A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol 44: 616–625.
-
72.
Caelli M, Porteous J, Carson CF, Heller R, Riley TV, 2000. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect 46: 236–237.
-
73.
Dryden MS, Dailly S, Crouch M, 2004. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect 56: 283–286.
-
74.
Enshaieh S, Jooya A, Siadat A, Iraji F, 2007. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian J Dermatol Venereol Leprol 73: 22–25.
-
75.
Satchell AC, Saurajen A, Bell C, Barnetson RS, 2002. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol 47: 852–855.
-
76.
Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA, 1999. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health 4: 284–287.
-
77.
Tong MM, Altman PM, Barnetson RS, 1992. Tea tree oil in the treatment of Tinea pedis. Australas J Dermatol 33: 145–149.
-
78.
Lee RLP, Leung PHM, Wong TKS, 2014. A randomized controlled trial of topical tea tree preparation for MRSA colonized wounds. Int J Nurs Sci 1: 7–14.
-
79.
Markum E, Baillie J, 2012. Combination of essential oil of Melaleuca alternifolia and iodine in the treatment of molluscum contagiosum in children. J Drugs Dermatol 11: 349–354.
-
80.
Aspres N, Freeman S, 2003. Predictive testing for irritancy and allergenicity of tea tree oil in normal human subjects. Exogenous Dermatol 2: 258–261.
-
81.
Lauten JD, Boyd L, Hanson MB, Lillie D, Gullion C, Madden TE, 2005. A clinical study: melaleuca, manuka, calendula and green tea mouth rinse. Phytother Res 19: 951–957.
-
82.
Jandourek A, Vaishampayan JK, Vazquez JA, 1998. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS 12: 1033–1037.
-
83.
Pazyar N, Yaghoobi R, Bagherani N, Kazerouni A, 2013. A review of applications of tea tree oil in dermatology. Int J Dermatol 52: 784–790.
-
84.
Callander JT, James PJ, 2012. Insecticidal and repellent effects of tea tree (Melaleuca alternifolia) oil against Lucilia cuprina. Vet Parasitol 184: 271–278.
-
85.
Yim WT, Bhandari B, Jackson L, James P, 2016. Repellent effects of Melaleuca alternifolia (tea tree) oil against cattle tick larvae (Rhipicephalus australis) when formulated as emulsions and in β-cyclodextrin inclusion complexes. Vet Parasitol 225: 99–103.
-
86.
Walton SF, McKinnon M, Pizzutto S, Dougall A, Williams E, Currie BJ, 2004. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of Sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol 140: 563–566.
-
87.
Murphy O, O’Dwyer V, Lloyd-McKernan A, 2018. The efficacy of tea tree face wash, 1, 2-Octanediol and microblepharoexfoliation in treating Demodex folliculorum blepharitis. Cont Lens Anterior Eye 41: 77–82.
-
88.
Lam NSK, Long XX, Griffin RC, Chen M-K, Doery JCG, 2018. Can the tea tree oil (Australian native plant: Melaleuca alternifolia Cheel) be an alternative treatment for human demodicosis on skin? Parasitology 145: 1510–1520.
-
89.
Lam NSK, Long XX, Li X, Yang L, Griffin RC, Doery JC, 2020. Comparison of the efficacy of tea tree (Melaleuca alternifolia) oil with other current pharmacological management in human demodicosis: a systematic review. Parasitology 147: 1587–1613.
-
90.
Canyon DV, Speare R, 2007. A comparison of botanical and synthetic substances commonly used to prevent head lice (Pediculus humanus var. capitis) infestation. Int J Dermatol 46: 422–426.
-
91.
Whitledge KL, 2002. Use of Essential Oils to Repel and Treat Head Lice. US: Google Patents.
-
92.
Eamsobhana P, Yoolek A, Kongkaew W, Lerdthusnee K, Khlaimanee N, Parsartvit A, Malainual N, Yong HS, 2009. Laboratory evaluation of aromatic essential oils from thirteen plant species as candidate repellents against Leptotrombidium chiggers (Acari: Trombiculidae), the vector of scrub typhus. Exp Appl Acarol 47: 257–262.
-
93.
Sukkanon C, Chareonviriyaphap T, Doggett SL, 2019. Topical and spatial repellent bioassays against the Australian paralysis tick, Ixodes holocyclus (Acari: Ixodidae). Austral Entomol 58: 866–874.
-
94.
Australian and New Zealand Clinical Trials Registry , 2019. Treatment of Tungiasis Using a Proprietary Tea Tree Oil (TTO)-gel Formulation in Children: Protocol for a Randomised, Controlled, Proof of Principle Trial. Available at: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378685. Accessed September 21, 2020.
-
95.
De Wolff R, 2008. Essential Oil Compositions for Killing or Repelling Ectoparasites and Pests and Methods for Use Thereof. Publication USPA US: Google Patents.
-
96.
Sudhir NKP, Padmananbhan SAR, 2017. Tick and Flea Control Compositions Comprising Plant Essential Oils and Different Forms for the Ease of Application. US US: Google Patents.
-
97.
Fitzjarrell EA, 1995. Method and Formulation for Eliminating Fleas on Animals. Patent US US: Google Patents.
-
98.
Colleen N, 2015. Non-toxic Ectoparasite Treatment Composition and Method of Use. World Intellectual Property Organization USA: Google Patents.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 23585 | 5972 | 60 |
| Full Text Views | 2971 | 85 | 24 |
| PDF Downloads | 160 | 63 | 25 |
Therapeutic Potential of Tea Tree Oil for Tungiasis
ABSTRACT.
Tungiasis (sand flea disease) is a neglected tropical disease caused by penetration of female sand fleas, Tunga penetrans, into a person’s skin usually in their feet. The disease inflicts immense pain and suffering on millions of people, particularly children. The condition is most prevalent in Latin America, the Caribbean, and sub-Saharan Africa. Currently, there is no standard drug treatment for tungiasis. The available treatment options are fairly limited and unrealistic to use in endemic areas; as a result, in desperation, the affected people do more harm to themselves by extracting the fleas with non-sterile instruments, further exposing themselves to secondary bacterial infections and/or transmission of diseases such as hepatitis B virus, hepatitis C virus, or HIV. This highlights the urgent need for simpler, safer, and effective treatment options for tungiasis. Tea tree oil (TTO) has long been used as an antiseptic with extensive safety and efficacy data. The evidence on parasiticidal properties of TTO against ectoparasites such as head lice, mites, and fleas is also compelling. The purpose of this review is to discuss the current tungiasis treatment challenges in endemic settings and highlight the potential role of TTO in the treatment of tungiasis.
Author Notes
Authors’ addresses: Solomon Abrha, Wubshet Tesfaye, and Jackson Thomas, Faculty of Health, University of Canberra, Bruce, Canberra, Australian Capital Territory, Australia, E-mails: solomon.bezabh@canberra.edu.auwubshet.tesfaye@canberra.edu.au, and jackson.thomas@canberra.edu.au.